Oncology Regional Business Director - South Central

Summit Therapeutics, Inc.; United States; On-site; USD 180,000 - 240,000; Full time

Job summary

Scorpion Therapeutics is seeking a Regional Business Director to oversee the launch and commercialization of an oncology product in the U.S. market.

You will drive regional sales, manage a field team of oncology account managers, and coordinate with Marketing, Medical Affairs, and Market Access to ensure a successful product launch. The ideal candidate has 10+ years in pharma/biotech sales with 5+ years in oncology leadership, strong leadership and data analysis skills, and recent NSCLC launch

Qualifications

• Bachelor's degree in business, life sciences, or related field.
• 10+ years in pharma/biotech sales with 5+ years in oncology sales leadership.
• Recent experience supporting oncology product launches, preferably NSCLC.

Responsibilities

• Execute sales strategies.
• Lead and develop a high-performing field team of oncology account managers.
• Drive regional sales and build customer relationships.
• Collaborate cross-functionally with Marketing, Medical Affairs, and Market Access.
• Ensure compliance.

Skills

Leadership

Data analysis

Coaching

Strategic sales

Education

Bachelor's degree in business or life sciences

Job description

Role

Regional Business Director overseeing the launch and commercialization of ivonescimab in the U.S. oncology market.

Responsibilities

execute sales strategies, lead and develop a high-performing field team of oncology account managers, drive regional sales, build customer relationships, collaborate cross-functionally with Marketing, Medical Affairs, and Market Access, and ensure compliance.

Requirements

Bachelor's degree in business, life sciences, or related field; 10+ years in pharma/biotech sales with 5+ years in oncology sales leadership; recent experience supporting oncology product launches, preferably NSCLC; strong leadership, coaching, and data analysis skills.

HighValue

Oncology (NSCLC, colorectal cancer), Phase 3 clinical stage, direct engagement with healthcare providers, and familiarity with oncology market dynamics; travel up to 75%.

WorkSetup

remote with extensive travel.